UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
SNUH gets ‘landmark’ FDA approval to test micro-dosing technology in Korea
Howard Lee, researcher and professor at Seoul National University Hospital ...
by Marian Chu
|
2018-02-07 14:27
라인
Is Dong-A shifting focus to generic drugs?
The pharmaceutical industry is paying attention to why Dong-A Pharmaceutica...
by Lee Hye-seon
|
2018-02-07 14:26
라인
HIRA nixes expanded insurance coverage for skin cancer drug
The Korean Health Insurance Review and Assessment Service (HIRA) said Monda...
by Marian Chu
|
2018-02-07 14:21
라인
Tego applies for P3 clinical trials for tendon rejuvenation therapy
Tego Science said Wednesday that it has applied to initiate phase 3 clinica...
by Lee Han-soo
|
2018-02-07 11:38
라인
Immunotherapies claims rose on insurance coverage in 2017
More health insurance coverage for expensive immunotherapies caused claims ...
by Nam Doo-hyun
|
2018-02-07 11:07
라인
Pharmaceutical industry sees rise in hiring, R&D investment
The domestic pharmaceutical industry marked increases in employment and R&D...
by Marian Chu
|
2018-02-07 10:17
라인
Medical support groups for Winter Games start services in ceremony
Wonju Severance Christian Hospital said it had mobilized 124 medical worker...
by Marian Chu
|
2018-02-06 18:17
라인
Cancer patients find relief with insurance coverage of 3 immunotherapies
The Ministry of Health and Welfare said Monday that it granted insurance co...
by Marian Chu
|
2018-02-06 17:25
라인
Seoul to spend ₩1 trillion on dementia
The government said it would spend 1 trillion won ($920 million) on researc...
by So Jae-hyeon
|
2018-02-06 16:26
라인
GE Healthcare to support PyeongChang Winter Olympics
GE Healthcare said Tuesday that it plans to provide various support ranging...
by Lee Han-soo
|
2018-02-06 16:18
라인
Government to expand hospitalist system to all general hospitals
The government will allow all general hospitals and the wards that use inte...
by Kwak Sung-sun
|
2018-02-06 15:23
라인
Spectrum unveils trial results for Hanmi’s neutropenia treatment
Spectrum Pharmaceuticals, a U.S.-based biotechnology company, announced Mon...
by Lee Han-soo
|
2018-02-06 14:44
라인
DongA-ST opens factory in Indonesia
DongA-ST said Tuesday that it has finished construction of “PT Combiphar Do...
by Lee Han-soo
|
2018-02-06 14:15
라인
Healthcare reporters boycott Novartis press releases
South Korea’s eight media companies specializing in healthcare news decided...
by Lee Han-soo
|
2018-02-06 13:26
라인
Korea’s first diagnostic agent for Alzheimer’s approved
The government on Friday approved the nation’s first diagnostic radiopharma...
by Lee Hye-seon
|
2018-02-06 10:48
라인
Sole candidate for KPA leadership makes absurd demands as 'pledges'
“The president of KPA should receive 20 million won ($18,338), after tax, i...
by Song Soo-youn
|
2018-02-05 17:19
라인
‘TNF inhibitors serve as non-invasive, regeneration method for arthritis’
Kyung Hee University Hospital in Gangdong said Monday that its research tea...
by Marian Chu
|
2018-02-05 17:14
라인
GC Pharma marks record sales
GC Pharma, formerly known as Green Cross, said Monday its sales hit a recor...
by Lee Han-soo
|
2018-02-05 16:59
라인
JW Pharm begins to sell treatment for respiratory distress syndrome in infants
JW Pharmaceuticals said Monday that it has started marketing Infasurf (Ingr...
by Lee Han-soo
|
2018-02-05 15:37
라인
AstraZeneca Korea elects Kim Sang-pyo as new CEO
AstraZeneca Korea said Kim Sang-pyo took office as its new CEO on Monday. K...
by Marian Chu
|
2018-02-05 14:47
-
이전
241
242
243
244
245
246
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top